Literature DB >> 17631569

Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.

L Toschi1, F Cappuzzo, P A Jänne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17631569     DOI： 10.1093/annonc/mdm311

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Tumour volume changes assessed with high-quality KVCT in lung cancer patients undergoing concurrent chemoradiotherapy.

Authors:  Y H Lee; Y S Kim; H C Lee; S W Lee; Y N Kang; J H Kang; S H Hong; Y K Kim; S J Kim; M I Ahn; D H Han; I R Yoo; J G Park; S W Sung; K Y Lee
Journal:  Br J Radiol       Date:  2015-06-09       Impact factor: 3.039

2.  In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles.

Authors:  Helen E Townley; Jeewon Kim; Peter J Dobson
Journal:  Nanoscale       Date:  2012-07-06       Impact factor: 7.790

3.  BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation.

Authors:  Y Loriot; P Mordant; N Dorvault; T De la motte Rouge; J Bourhis; J-C Soria; E Deutsch
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

4.  Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.

Authors:  Yun Hee Lee; Yeon Sil Kim; Sang Nam Lee; Hyo Chun Lee; Se Jin Oh; Seoung Joon Kim; Young Kyoon Kim; Dae Hee Han; Ie Ryung Yoo; Jin Hyung Kang; Suk Hee Hong
Journal:  Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.679

5.  MicroRNA‑29a enhances cisplatin sensitivity in non‑small cell lung cancer through the regulation of REV3L.

Authors:  Xialin Chen; Hong Zhu; Wanli Ye; Yayun Cui; Ming Chen
Journal:  Mol Med Rep       Date:  2018-12-04       Impact factor: 2.952

6.  Epigenetic silencing of microRNA-199a-5p promotes the proliferation of non-small cell lung cancer cells by increasing AKAP1 expression.

Authors:  Nengli Yang; Yafeng Liang; Tianqi Zhu; Yanxiao Long; Zhe Chen; Xuezheng Zhang; Liuming Jiang
Journal:  Oncol Lett       Date:  2021-03-31       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.